Palvella Therapeutics, Inc. (PVLA) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$130.5
Day's range
$138.89

Palvella Therapeutics Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
SUVRETTA CAPITAL MANAGEMENT, LLC 05/15/2026 1.15 M $143.78 M   29.26% 10.25%
FIRST LIGHT ASSET MANAGEMENT, LLC 05/15/2026 980.76 K $122.25 M   38.30% 8.72%
BVF INC/IL 05/15/2026 960.99 K $119.79 M   9.33% 8.54%
FRAZIER LIFE SCIENCES MANAGEMENT, L.P. 05/15/2026 882.40 K $109.99 M   22.15% 7.84%
BLACKROCK, INC. 05/13/2026 686.85 K $85.62 M   22.86% 6.10%
JENNISON ASSOCIATES LLC 05/06/2026 640.61 K $79.85 M   65.33% 5.69%
05/15/2026 477.29 K $59.49 M   100.00% 4.24%
STATE STREET CORP 05/15/2026 459.00 K $57.21 M   9.17% 4.08%
FEDERATED HERMES, INC. 05/11/2026 433.02 K $53.98 M   17.66% 3.85%
PRICE T ROWE ASSOCIATES INC /MD/ 05/15/2026 402.56 K $50.18 M   9,742.64% 3.58%
FRONTIER CAPITAL MANAGEMENT CO LLC 05/15/2026 374.04 K $46.62 M   100.00% 3.32%
WOODLINE PARTNERS LP 05/15/2026 317.52 K $39.58 M   5.65% 2.82%
ALLIANCEBERNSTEIN L.P. 05/15/2026 262.84 K $27.51 M   -2.30% 2.34%
SIREN, L.L.C. 05/14/2026 257.49 K $32.10 M   243.31% 2.29%
EVENTIDE ASSET MANAGEMENT, LLC 05/15/2026 233.25 K $29.05 M   129.24% 2.07%
FMR LLC 05/15/2026 215.81 K $26.90 M   -6.88% 1.92%
BIOIMPACT CAPITAL LLC 05/15/2026 206.40 K $25.73 M   0.32% 1.83%
GEODE CAPITAL MANAGEMENT, LLC 05/15/2026 205.61 K $25.64 M   14.87% 1.83%
PRIMECAP MANAGEMENT CO/CA/ 05/11/2026 195.03 K $24.31 M   100.00% 1.73%
GOLDMAN SACHS GROUP INC 05/15/2026 194.18 K $24.20 M   96.27% 1.73%
ARTISAN PARTNERS LIMITED PARTNERSHIP 05/13/2026 193.80 K $24.16 M   -8.39% 1.72%
ALYESKA INVESTMENT GROUP, L.P. 05/15/2026 179.92 K $22.43 M   100.00% 1.60%
CAPTION MANAGEMENT, LLC 05/15/2026 170.00 K $21.19 M   77.08% 1.51%
EMERALD ADVISERS, LLC 05/04/2026 161.50 K $20.13 M   100.00% 1.44%
FIRST TURN MANAGEMENT, LLC 05/15/2026 148.09 K $18.46 M   100.00% 1.32%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 05/15/2026 141.60 K $17.65 M   270.68% 1.26%
ORBIMED ADVISORS LLC 05/15/2026 134.60 K $16.78 M   100.00% 1.20%
MORGAN STANLEY 05/15/2026 127.99 K $15.95 M   -42.00% 1.14%
EMERALD MUTUAL FUND ADVISERS TRUST 05/04/2026 105.82 K $13.19 M   100.00% 0.94%
UBS GROUP AG 05/05/2026 104.54 K $13.03 M   186.36% 0.93%
BALYASNY ASSET MANAGEMENT L.P. 05/15/2026 96.73 K $12.06 M   -11.16% 0.86%
MILLENNIUM MANAGEMENT LLC 05/15/2026 93.65 K $11.67 M   2,590.98% 0.83%
05/08/2026 90.86 K $11.33 M   100.00% 0.81%
CLIO ASSET MANAGEMENT LLC 04/21/2026 90.76 K $11.31 M   -0.97% 0.81%
APIS CAPITAL ADVISORS, LLC 05/15/2026 89.00 K $11.09 M   100.00% 0.79%
POINT72 ASSET MANAGEMENT, L.P. 05/15/2026 88.16 K $10.99 M   14.05% 0.78%
05/14/2026 82.69 K $10.31 M   0.00% 0.73%
ABRDN PLC 04/29/2026 81.08 K $10.11 M   100.00% 0.72%
AVIDITY PARTNERS MANAGEMENT LP 05/28/2026 70.00 K $8.73 M   262.69% 0.62%
UBS ASSET MANAGEMENT AMERICAS INC 05/13/2026 69.90 K $8.71 M   46.60% 0.62%
AWM INVESTMENT COMPANY, INC. 05/15/2026 69.42 K $8.65 M   0.00% 0.62%
CAPTION MANAGEMENT, LLC 05/15/2026 67.10 K $8.36 M   -29.59% 0.60%
VANGUARD FIDUCIARY TRUST CO 05/08/2026 64.78 K $8.08 M   100.00% 0.58%
IKARIAN CAPITAL, LLC 05/15/2026 64.63 K $8.06 M   100.00% 0.57%
NORTHERN TRUST CORP 05/14/2026 64.37 K $8.02 M   18.13% 0.57%
SEVEN GRAND MANAGERS, LLC 05/06/2026 60.00 K $7.48 M   100.00% 0.53%
CLEARBRIDGE INVESTMENTS, LLC 05/13/2026 59.41 K $7.41 M   -2.01% 0.53%
ORBIMED ADVISORS LLC 05/15/2026 50.00 K $6.23 M   100.00% 0.44%
NEUBERGER BERMAN GROUP LLC 05/14/2026 49.10 K $6.12 M   9.36% 0.44%
INVESCO LTD. 05/12/2026 48.53 K $6.05 M   -10.59% 0.43%

Palvella Therapeutics Inc. institutional Ownership - FAQ's

During the previous two years, 202 institutional investors and hedge funds held shares of Palvella Therapeutics Inc.. The most heavily invested institutionals were:

SUVRETTA CAPITAL MANAGEMENT, LLC: 1.15 M

First Light Asset Management, LLC: 980,758

BVF INC/IL: 960,989

Frazier Life Sciences Management, L.P.: 882,400

BlackRock, Inc.: 686,853

JENNISON ASSOCIATES LLC: 640,611

117.39% of Palvella Therapeutics Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 13.13 M shares in the last 24 months. This purchase volume represents approximately $1.80 B in transactions.